Lactoferrin as a natural regimen for selective decontamination of the digestive tract: Recombinant porcine lactoferrin expressed in the milk of transgenic mice protects neonates from pathogenic challenge in the gastrointestinal tract

Journal of Infectious Diseases

Volumn 199, Issue 4, 2009, Pages 590-598

  Yen, Chih Ching ^a,b   Lin, Chien Yu ^a   Chong, Kowit Yu ^d   Tsai, Tung Chou ^a   Shen, Chih Jie ^a   Lin, Ming Fong ^a,c   Su, Chun Yao ^a   Chen, Hsiao Ling ^e   Chen, Chuan Mu ^a  

^a NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c TAICHUNG HOSPITAL   (Taiwan)

^d CHANG GUNG UNIVERSITY   (Taiwan)

^e DA YEH UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

LACTOFERRIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL COUNT; CANDIDA ALBICANS; CONTROL GROUP; CONTROLLED STUDY; DISEASE MODEL; ESCHERICHIA COLI; INFECTION PREVENTION; INTESTINE BRUSH BORDER; INTESTINE FLUID; INTESTINE INFECTION; INTESTINE INJURY; LACTATION; LUNG ALVEOLUS; MILK; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; SMALL INTESTINE; STAPHYLOCOCCUS AUREUS; TRANSGENIC MOUSE; WEIGHT GAIN; WILD TYPE;

ANIMALS; ANIMALS, NEWBORN; BACTEREMIA; BACTERIAL INFECTIONS; BODY WEIGHT; CANDIDIASIS; CYTOKINES; ESCHERICHIA COLI INFECTIONS; GASTROINTESTINAL TRACT; IMMUNOHISTOCHEMISTRY; INTESTINES; LACTATION; LACTOFERRIN; LUNG; MICE; MICE, TRANSGENIC; MILK; POLYMERASE CHAIN REACTION; RECOMBINANT PROTEINS; STAPHYLOCOCCAL INFECTIONS; SWINE;

EID: 61849184878     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/596212     Document Type: Article

References (37)

1. Jones RN. Resistance patterns among nosocomial pathogens: trends over the past few years. Chest 2001; 119:397S-404S.
2. De Jonge E, Schultz MJ, Spanjaard L, et al. Effects of selective decontamination of digestive tract on mortality and acquisition of resistant bacteria in intensive care: a randomised controlled trial. Lancet 2003; 362:1011-6.
3. Bonten MJ, Grundmann H. Selective digestive decontamination and antibiotic resistance: a balancing act. Crit Care Med 2003; 31:2239-40.
4. Pittet D, Eggimann P, Rubinovitch B. Prevention of ventilator-associated pneumonia by oral decontamination: just another SDD study? Am J Respir Crit Care Med 2001; 164:338-9.
5. Camus C, Bellissant E, Sebille V, et al. Thomas R. Prevention of acquired infections in intubated patients with the combination of two decontamination regimens. Crit Care Med 2005; 33:307-14.
6. Vincent JL. Selective digestive decontamination: for everyone, everywhere? Lancet 2003; 362:1006-7.
7. Valenti P, Antonini G. Lactoferrin: an important host defence against microbial and viral attack. Cell Mol Life Sci 2005; 62:2576-87.
8. Tomita M, Wakabayashi H, Yamauchi K, Teraguchi S, Hayasawa H. Bovine lactoferrin and lactoferricin derived from milk: production and applications. Biochem Cell Biol 2002; 80:109-12.
9. Kim WS, Ohashi M, Tanaka T, et al. Growth-promoting effects of lactoferrin on L. acidophilus and Bifidobacterium spp. Biometals 2004; 17:279-83.
10. Chen HL, Lai YW, Yen CC, et al. Production of recombinant porcine lactoferrin exhibiting antibacterial activity in methylotrophic yeast, Pichia pastoris. J Mol Microbiol Biotechnol 2004; 8:141-9.
11. Chen HL, Yen CC, Lu CY, Yu CH, Chen CM. Synthetic porcine lactoferricin with a 20-residue peptide exhibits antimicrobial activity against Escherichia coli, Staphylococcus aureus, and Candida albicans. J Agric Food Chem 2006; 54:3277-82.
12. Wang Y, Han F, Xu Z. Developmental gene expression of lactoferrin in duodenum and effect of weaning age on gene expression of lactoferrin in piglets. Arch Anim Nutr 2006; 60:1-9.
13. Lee WJ, Farmer JL, Hilty M, Kim YB. The protective effects of lactoferrin feeding against endotoxin lethal shock in germfree piglets. Infect Immun 1998; 66:1421-6.
14. Wu SC, Chen HL, Yen CC, et al. Recombinant porcine lactoferrin expressed in the milk of transgenic mice enhances offspring growth performance. J Agric Food Chem 2007; 55:4670-7.
15. Chen CM, Wang CH, Wu SC, Lin CC, Lin SH, Cheng WTK. Temporal and spatial expression of biologically active human factor VIII in the milk of transgenic mice driven by mammary-specific bovine-lactalbumin regulation sequences. Transgenic Res 2002; 11:257-68.
16. Chen PW, Shyu CL, Mao FC. Effects of bovine lactoferrin hydrolysate on the in vitro antimicrobial susceptibility of Escherichia coli strains isolated from baby pigs. Am J Vet Res 2004; 65:131-7.
17. Takakura N, Wakabayashi H, Ishibashi H, et al. Oral lactoferrin treatment of experimental oral Candidiasis in mice. Antimicrob Agents Chemother 2003; 47:2619-23.
18. Chen HL, Wang LC, Chang CH, et al. Recombinant porcine lactoferrin expressed in the milk of transgenic mice protects neonatal mice from a lethal challenge with enterovirus type 71. Vaccine 2008; 26:891-8.
19. Pecorini C, Savazzini F, Martino PA, Fusi E, Fogher C, Baldi A. Heterologous expression of biologically active porcine lactoferrin in Pichia pastoris yeast. Vet Res Commun 2005; 29:379-82.
20. Chen HL, Huang JY, Chu TW, et al. Expression of VP1 protein in the milk of transgenic mice: a potential oral vaccine against enterovirus 71 infection. Vaccine 2008; 26:2882-9.
21. Edde L, Hipolito RB, Hwang FF, Headon DR, Shalwitz RA, Sherman MP. Lactoferrin protects neonatal rats from gut-related systemic infection. Am J Physiol Gastrointest Liver Physiol 2001; 281:G1140-50.
22. Haversen LA, Engberg I, Baltzer L, Dolphin G, Hanson LA, Mattsby-Baltzer I. Human lactoferrin and peptides derived from a surface-exposed helical region reduce experimental Escherichia coli urinary tract infection in mice. Infect Immun 2000; 68:5816-23.
23. Teraguchi S, Shin K, Ogata T, et al. Orally administered bovine lactoferrin inhibits bacterial translocation in mice fed bovine milk. Appl Environ Microbiol 1995; 61:4131-4.
24. Bhimani RS, Vendrov Y, Furmanski P. Influence of lactoferrin feeding and injection against systemic staphylococcal infections in mice. J Appl Microbiol 1999; 86:135-44.
25. Hutchens TW, Henry JF, Yip TT. Structurally intact (78-kDa) forms of maternal lactoferrin purified from urine of preterm infants fed human milk: identification of a trypsin-like proteolytic cleavage event in vivo that does not result in fragment dissociation. Proc Natl Acad Sci USA 1991; 88:2994-8.
26. Legrand D, Vigie K, Said EA, et al. Surface nucleolin participates in both the binding and endocytosis of lactoferrin in target cells. Eur J Biochem 2004; 271:303-17.
27. Yamauchi K, Wakabayashi H, Shin K, Takase M. Bovine lactoferrin: benefits and mechanism of action against infections. Biochem Cell Biol 2006; 84:291-6.
28. Venkatesh MP, Pham D, Kong L, Weisman LE. Prophylaxis with lactoferrin, a novel antimicrobial agent, in a neonatal rat model of coinfection. Adv Ther 2007; 24:941-54.
29. Murdock CA, Cleveland J, Matthews KR, Chikindas ML. The synergistic effect of nisin and lactoferrin on the inhibition of Listeria monocytogenes and Escherichia coli O157:H7. Lett Appl Microbiol 2007; 44:255-61.
30. Lee HY, Park JH, Seok SH, et al. Potential antimicrobial effects of human lactoferrin against oral infection with Listeria monocytogenes in mice. J Med Microbiol 2005; 54:1049-54.
31. Kuipers ME, de Vries HG, Eikelboom MC, Meijer DK, Swart PJ. Synergistic fungistatic effects of lactoferrin in combination with antifungal drugs against clinical Candida isolates. Antimicrob Agents Chemother 1999; 43:2635-41.
32. Viejo-Diaz M, Andres MT, Fierro JF. Modulation of in vitro fungicidal activity of human lactoferrin against Candida albicans by extracellular cation concentration and target cell metabolic activity. Antimicrob Agents Chemother 2004; 48:1242-8.
33. Singh PK, Parsek MR, Greenberg EP, Welsh MJ. A component of innate immunity prevents bacterial biofilm development. Nature 2002; 417:552-5.
34. Ashida K, Sasaki H, Suzuki YA, Lonnerdal B. Cellular internalization of lactoferrin in intestinal epithelial cells. Biometals 2004; 17:311-5.
35. Hyvonen P, Suojala L, Haaranen J, von Wright A, Pyorala S. Human and bovine lactoferrins in the milk of recombinant human lactoferrin-transgenic dairy cows during lactation. Biotechnol J 2006; 1:410-2.
36. Song MC, Kellum JA. Interleukin-6 (review). Crit Care Med 2005; 33:S463-5.
37. Sfeir RM, Dubarry M, Boyaka PN, Rautureau M, Tome D. The mode of oral bovine lactoferrin administration influences mucosal and systemic immune responses in mice. J Nutr 2004; 134:403-9.